Fatal adverse event reported in Chinese pediatric gene therapy clinical trial

A six-year-old participant died during an experimental gene therapy trial for a non-lethal condition in China, according to an investigation by Science. The incident raises significant concerns regarding clinical trial oversight, patient safety protocols, and the regulatory environment for advanced therapies in the region.